265 related articles for article (PubMed ID: 31476940)
1. Contemporary Role of Topical Calcineurin Inhibitors: A Pediatric Dermatology Perspective.
Fiorillo L; Marcoux D; Ramien M
J Cutan Med Surg; 2019; 23(4_suppl):11S-18S. PubMed ID: 31476940
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
[TBL] [Abstract][Full Text] [Related]
3. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
Hong CH; Gooderham M; Bissonnette R
J Cutan Med Surg; 2019; 23(4_suppl):5S-10S. PubMed ID: 31476937
[TBL] [Abstract][Full Text] [Related]
4. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations.
Carr WW
Paediatr Drugs; 2013 Aug; 15(4):303-10. PubMed ID: 23549982
[TBL] [Abstract][Full Text] [Related]
5. What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?
Hanna S; Zip C; Shear NH
J Cutan Med Surg; 2019; 23(4_suppl):19S-26S. PubMed ID: 31476938
[TBL] [Abstract][Full Text] [Related]
6. Position statement: topical calcineurin inhibitors in atopic dermatitis.
Remitz A; De Pità O; Mota A; Serra-Baldrich E; Vakirlis E; Kapp A
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2074-2082. PubMed ID: 30288799
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
9. Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.
Orlow SJ
Paediatr Drugs; 2007; 9(5):289-99. PubMed ID: 17927301
[TBL] [Abstract][Full Text] [Related]
10. A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.
Lebwohl M; Gower T
MedGenMed; 2006 Oct; 8(4):8. PubMed ID: 17415290
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
Kalavala M; Dohil MA
Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
[TBL] [Abstract][Full Text] [Related]
12. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
Luger T; Boguniewicz M; Carr W; Cork M; Deleuran M; Eichenfield L; Eigenmann P; Fölster-Holst R; Gelmetti C; Gollnick H; Hamelmann E; Hebert AA; Muraro A; Oranje AP; Paller AS; Paul C; Puig L; Ring J; Siegfried E; Spergel JM; Stingl G; Taieb A; Torrelo A; Werfel T; Wahn U
Pediatr Allergy Immunol; 2015 Jun; 26(4):306-15. PubMed ID: 25557211
[TBL] [Abstract][Full Text] [Related]
13. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Munzenberger PJ; Montejo JM
Pharmacotherapy; 2007 Jul; 27(7):1020-8. PubMed ID: 17594208
[TBL] [Abstract][Full Text] [Related]
14. Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis.
Chia BK; Tey HL
Dermatitis; 2015; 26(3):122-32. PubMed ID: 25984688
[TBL] [Abstract][Full Text] [Related]
15. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
16. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
Draelos ZD
Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
[TBL] [Abstract][Full Text] [Related]
17. A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas.
Reda AM; Elgendi A; Ebraheem AI; Aldraibi MS; Qari MS; Abdulghani MMR; Luger T
J Dermatolog Treat; 2019 Jun; 30(4):366-373. PubMed ID: 30222017
[No Abstract] [Full Text] [Related]
18. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
Frankel HC; Qureshi AA
Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
[TBL] [Abstract][Full Text] [Related]
19. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.
Siegfried EC; Jaworski JC; Hebert AA
Am J Clin Dermatol; 2013 Jun; 14(3):163-78. PubMed ID: 23703374
[TBL] [Abstract][Full Text] [Related]
20. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
